SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062082
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:39
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atha-20230930.htm   iXBRL 10-Q 2678259
2 EX-31.1 atha-ex31_1.htm EX-31.1 16919
3 EX-31.2 atha-ex31_2.htm EX-31.2 16805
4 EX-32.1 atha-ex32_1.htm EX-32.1 9661
5 EX-32.2 atha-ex32_2.htm EX-32.2 8368
6 GRAPHIC img105246694_0.jpg GRAPHIC 154086
  Complete submission text file 0000950170-23-062082.txt   8687696

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atha-20230930_def.xml EX-101.DEF 145458
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atha-20230930.xsd EX-101.SCH 52182
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atha-20230930_lab.xml EX-101.LAB 406735
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atha-20230930_cal.xml EX-101.CAL 40787
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atha-20230930_pre.xml EX-101.PRE 287015
59 EXTRACTED XBRL INSTANCE DOCUMENT atha-20230930_htm.xml XML 1403317
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39503 | Film No.: 231392649
SIC: 2836 Biological Products, (No Diagnostic Substances)